These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35440446)

  • 1. Protocol for the COG-UK hospital-onset COVID-19 infection (HOCI) multicentre interventional clinical study: evaluating the efficacy of rapid genome sequencing of SARS-CoV-2 in limiting the spread of COVID-19 in UK NHS hospitals.
    Blackstone J; Stirrup O; Mapp F; Panca M; Copas A; Flowers P; Hockey L; Price J; Partridge D; Peters C; de Silva T; Nebbia G; Snell LB; McComish R; ; Breuer J
    BMJ Open; 2022 Apr; 12(4):e052514. PubMed ID: 35440446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: Multicentre, prospective study.
    Stirrup O; Blackstone J; Mapp F; MacNeil A; Panca M; Holmes A; Machin N; Shin GY; Mahungu T; Saeed K; Saluja T; Taha Y; Mahida N; Pope C; Chawla A; Cutino-Moguel MT; Tamuri A; Williams R; Darby A; Robertson DL; Flaviani F; Nastouli E; Robson S; Smith D; Loose M; Laing K; Monahan I; Kele B; Haldenby S; George R; Bashton M; Witney AA; Byott M; Coll F; Chapman M; Peacock SJ; ; ; Hughes J; Nebbia G; Partridge DG; Parker M; Price JR; Peters C; Roy S; Snell LB; de Silva TI; Thomson E; Flowers P; Copas A; Breuer J
    Elife; 2022 Sep; 11():. PubMed ID: 36098502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the cost implications of integrating SARS-CoV-2 genome sequencing for infection prevention and control investigation of nosocomial transmission within hospitals.
    Panca M; Blackstone J; Stirrup O; Cutino-Moguel MT; Thomson E; Peters C; Snell LB; Nebbia G; Holmes A; Chawla A; Machin N; Taha Y; Mahungu T; Saluja T; de Silva TI; Saeed K; Pope C; Shin GY; Williams R; Darby A; Smith DL; Loose M; Robson SC; Laing K; Partridge DG; Price JR; Breuer J
    J Hosp Infect; 2023 Sep; 139():23-32. PubMed ID: 37308063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.
    Stirrup O; Hughes J; Parker M; Partridge DG; Shepherd JG; Blackstone J; Coll F; Keeley A; Lindsey BB; Marek A; Peters C; Singer JB; ; Tamuri A; de Silva TI; Thomson EC; Breuer J
    Elife; 2021 Jun; 10():. PubMed ID: 34184637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple pathways of SARS-CoV-2 nosocomial transmission uncovered by integrated genomic and epidemiological analyses during the second wave of the COVID-19 pandemic in the UK.
    Cook KF; Beckett AH; Glaysher S; Goudarzi S; Fearn C; Loveson KF; Elliott S; Wyllie S; Lloyd A; Bicknell K; Lumley S; Chauhan AJ; Robson SC;
    Front Cell Infect Microbiol; 2022; 12():1066390. PubMed ID: 36741977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
    Halford S; Wan S; Dragoni I; Silvester J; Nazarov B; Anthony D; Anthony S; Ladds E; Norrie J; Dhaliwal K;
    Trials; 2021 Aug; 22(1):550. PubMed ID: 34412682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of interventions to reduce nosocomial transmission of SARS-CoV-2 in English NHS Trusts: a computational modelling study.
    Evans S; Stimson J; Pople D; White PJ; Wilcox MH; Robotham JV
    BMC Infect Dis; 2024 May; 24(1):475. PubMed ID: 38714946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study.
    Meredith LW; Hamilton WL; Warne B; Houldcroft CJ; Hosmillo M; Jahun AS; Curran MD; Parmar S; Caller LG; Caddy SL; Khokhar FA; Yakovleva A; Hall G; Feltwell T; Forrest S; Sridhar S; Weekes MP; Baker S; Brown N; Moore E; Popay A; Roddick I; Reacher M; Gouliouris T; Peacock SJ; Dougan G; Török ME; Goodfellow I
    Lancet Infect Dis; 2020 Nov; 20(11):1263-1272. PubMed ID: 32679081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
    García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
    Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining epidemiological data and whole genome sequencing to understand SARS-CoV-2 transmission dynamics in a large tertiary care hospital during the first COVID-19 wave in The Netherlands focusing on healthcare workers.
    Haanappel CP; Oude Munnink BB; Sikkema RS; Voor In 't Holt AF; de Jager H; de Boever R; Koene HHHT; Boter M; Chestakova IV; van der Linden A; Molenkamp R; Osbak KK; Arcilla MS; Vos MC; Koopmans MPG; Severin JA
    Antimicrob Resist Infect Control; 2023 May; 12(1):46. PubMed ID: 37165456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superspreaders drive the largest outbreaks of hospital onset COVID-19 infections.
    Illingworth CJ; Hamilton WL; Warne B; Routledge M; Popay A; Jackson C; Fieldman T; Meredith LW; Houldcroft CJ; Hosmillo M; Jahun AS; Caller LG; Caddy SL; Yakovleva A; Hall G; Khokhar FA; Feltwell T; Pinckert ML; Georgana I; Chaudhry Y; Curran MD; Parmar S; Sparkes D; Rivett L; Jones NK; Sridhar S; Forrest S; Dymond T; Grainger K; Workman C; Ferris M; Gkrania-Klotsas E; Brown NM; Weekes MP; Baker S; Peacock SJ; Goodfellow IG; Gouliouris T; de Angelis D; Török ME
    Elife; 2021 Aug; 10():. PubMed ID: 34425938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Hospital-Onset SARS-CoV-2 Infection Rates and Testing Practices in the US, 2020-2022.
    Hatfield KM; Baggs J; Maillis A; Warner S; Jernigan JA; Kadri SS; Klompas M; Reddy SC
    JAMA Netw Open; 2023 Aug; 6(8):e2329441. PubMed ID: 37639273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study.
    Mo Y; Eyre DW; Lumley SF; Walker TM; Shaw RH; O'Donnell D; Butcher L; Jeffery K; Donnelly CA; ; Cooper BS
    PLoS Med; 2021 Oct; 18(10):e1003816. PubMed ID: 34637439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.